 Why Pharmaceutical Exports from India to Europe Grew During Economic Crisis?Arundhati Sarkar Bose Management and Labour Studies, 2017, vol. 42, issue 1, 39-58 Abstract: This article looks into the export trends of pharmaceuticals from India to selected destinations in Europe during the time period 2005–2014. Ten countries of Europe have been selected and divided into two groups—those that are more affected by the crisis beginning in 2008, and those that are less affected. The first group maintained a negative growth rate of GDP more consistently than the second group during the period of study. We found that India’s pharmaceutical exports to European countries, which are relatively more affected by economic crisis, in the time period of study, have increased despite falling income and falling per capita pharmaceutical expenditure. This article investigates the reasons for such trends in exports. Health care and pharmaceutical expenditures in the selected European destinations are largely publicly provided and have been subject to cost-containment policies. The austerity measures in Europe, as they were carried out in health care provision, India’s cost advantage in pharmaceuticals and its advantage as a generic producer and exporter are likely positive contributors to this growth. Keywords: Pharmaceuticals; trade; India; Europe; austerity (search for similar items in EconPapers) Downloads: (external link) Related works: Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text Persistent link: https://EconPapers.repec.org/RePEc:sae:manlab:v:42:y:2017:i:1:p:39-58 Access Statistics for this article More articles in Management and Labour Studies from XLRI Jamshedpur, School of Business Management & Human Resources |
Is your work missing from RePEc? Here is how to contribute.
Questions or problems? Check the EconPapers FAQ or send mail to .
EconPapers is hosted by the
School of Business at Örebro University.